Ceftriaxone and MC-100093 mitigate fentanyl-induced cardiac injury in mice: Preclinical investigation of its underlying molecular mechanisms
Saudi Pharmaceutical Journal · 2024-09 · 32 (9) · 102148
DOI: 10.1016/j.jsps.2024.102148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, 2024-09. Verfasst von Abdullah F AlAsmari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Drug addiction is considered a worldwide concern and one of the most prevailing causes of death globally. Opioids are highly addictive drugs, and one of the most common opioids that is frequently used clinically is fentanyl. The potential harmful effects of chronic exposure to opioids on the heart are still to be elucidated. Although β-lactam antibiotics are well recognized for their ability to fight bacteria, its protective effect in the brain and liver has been reported. In this study, we hypothesize that β-lactam antibiotic, ceftriaxone, and the novel synthetic non-antibiotic β-lactam, MC-100093, are cardioprotective against fentanyl induced-cardiac injury by upregulating xCT expression. Mice were exposed to repeated low dose (0.05 mg/kg, i.p.) of fentanyl for one week and then challenged on day 9 with higher dose of fentanyl (1 mg/kg, i.p.). This study investigated cardiac histopathology and target genes and proteins in serum and cardiac tissues in mice exposed to fentanyl overdose and β-lactams. We revealed that fentanyl treatment induced cardiac damage as evidenced by elevated cardiac enzymes (troponin I). Furthermore, fentanyl treatment caused large aggregations of inflammatory cells and elevation in the areas and volumes of myocardial fibers, indicating hypertrophy and severe cardiac damage. Ceftriaxone and MC-100093 treatment, However, induced cardioprotective effects as evidenced by marked reduction in cardiac enzymes (troponin I) and changes in histopathology. Furthermore, ceftriaxone and MC-100093 treatment decreased the levels of hypertrophic genes (α-MHC & β-MHC), apoptotic (caspase-3), and inflammatory markers (IL-6 & NF-κB). This study reports for the first time the cardioprotective effect of β-lactams against fentanyl-induced cardiac injury. Further studies are greatly encouraged to completely identify the cardioprotective properties of ceftriaxone and MC-100093.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, USA.
- Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA.
- Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Förderung
- King Saud University
Zitieren
APA
AlAsmari, A. F., Alshehri, M. M., Ali, N., AlAsmari, F., Sari, Y., Childers, W. E., Abou-Gharbia, M., Alharbi, M., Elnagar, D. M., & Al-Qahtani, W. S. (2024). Ceftriaxone and MC-100093 mitigate fentanyl-induced cardiac injury in mice: Preclinical investigation of its underlying molecular mechanisms. Saudi Pharmaceutical Journal, 32(9), 102148. https://doi.org/10.1016/j.jsps.2024.102148
Vancouver
AlAsmari AF, Alshehri MM, Ali N, AlAsmari F, Sari Y, Childers WE, et al. Ceftriaxone and MC-100093 mitigate fentanyl-induced cardiac injury in mice: Preclinical investigation of its underlying molecular mechanisms. Saudi Pharmaceutical Journal. 2024;32(9):102148. doi:10.1016/j.jsps.2024.102148
BibTeX
@article{AlAsmari2024,
author = {AlAsmari, Abdullah F and Alshehri, Mohammed M and Ali, Nemat and AlAsmari, Fawaz and Sari, Youssef and Childers, Wayne E and Abou-Gharbia, Magid and Alharbi, Metab and Elnagar, Doaa M and Al-Qahtani, Wejdan S},
title = {Ceftriaxone and MC-100093 mitigate fentanyl-induced cardiac injury in mice: Preclinical investigation of its underlying molecular mechanisms},
journal = {Saudi Pharmaceutical Journal},
year = {2024},
volume = {32},
number = {9},
pages = {102148},
doi = {10.1016/j.jsps.2024.102148}
}
EUVIMED